Defence Therapeutics Stock Analysis
| DTCFF Stock | USD 0.79 0.08 9.20% |
Defence Therapeutics is overvalued with Real Value of 0.63 and Hype Value of 0.79. The main objective of Defence Therapeutics otc analysis is to determine its intrinsic value, which is an estimate of what Defence Therapeutics is worth, separate from its market price. There are two main types of Defence Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Defence Therapeutics otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Defence Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
Defence |
Defence OTC Stock Analysis Notes
The company recorded a loss per share of 0.15. Defence Therapeutics had not issued any dividends in recent years. Defence Therapeutics Inc., a biotechnology company, engages in the research and development of biologicalbiosimilar therapeutic drugs for cancer and infectious diseases. Defence Therapeutics Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada. Defence Therapeutics is traded on OTC Exchange in the United States.The quote for Defence Therapeutics is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To learn more about Defence Therapeutics call Sebastien Plouffe at 514 947 2272 or check out https://defencetherapeutics.com.Defence Therapeutics Investment Alerts
| Defence Therapeutics is way too risky over 90 days horizon | |
| Defence Therapeutics has some characteristics of a very speculative penny stock | |
| Defence Therapeutics appears to be risky and price may revert if volatility continues | |
| Defence Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company has a current ratio of 0.6, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Defence Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Defence Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Defence Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Defence to invest in growth at high rates of return. When we think about Defence Therapeutics' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (7.34 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Defence Therapeutics has accumulated about 506.7 K in cash with (6.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
Defence Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 143.45 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Defence Therapeutics's market, we take the total number of its shares issued and multiply it by Defence Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 1st of March, Defence Therapeutics shows the Mean Deviation of 6.35, coefficient of variation of 747.74, and Downside Deviation of 19.75. Defence Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Defence Therapeutics, which can be compared to its peers. Please confirm Defence Therapeutics coefficient of variation, maximum drawdown, skewness, as well as the relationship between the information ratio and downside variance to decide if Defence Therapeutics is priced favorably, providing market reflects its regular price of 0.79 per share. As Defence Therapeutics is a penny stock we also recommend to verify its total risk alpha numbers.Defence Therapeutics Price Movement Analysis
The output start index for this execution was four with a total number of output elements of fifty-seven. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Defence Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Defence Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Defence Therapeutics Predictive Daily Indicators
Defence Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Defence Therapeutics otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.91 | |||
| Day Median Price | 0.79 | |||
| Day Typical Price | 0.79 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.08) | |||
| Relative Strength Index | 73.6 |
Defence Therapeutics Forecast Models
Defence Therapeutics' time-series forecasting models are one of many Defence Therapeutics' otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Defence Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Defence OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Defence Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Defence shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Defence Therapeutics. By using and applying Defence OTC Stock analysis, traders can create a robust methodology for identifying Defence entry and exit points for their positions.
Defence Therapeutics Inc., a biotechnology company, engages in the research and development of biologicalbiosimilar therapeutic drugs for cancer and infectious diseases. Defence Therapeutics Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada. Defence Therapeutics is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Defence Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
Complementary Tools for Defence OTC Stock analysis
When running Defence Therapeutics' price analysis, check to measure Defence Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Defence Therapeutics is operating at the current time. Most of Defence Therapeutics' value examination focuses on studying past and present price action to predict the probability of Defence Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Defence Therapeutics' price. Additionally, you may evaluate how the addition of Defence Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |